Search results for:
fluticasone-vilanterol
fluticasone-vilanterol
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Breo Ellipta |
POWDER, INHALATION |
100 mcg-25 mcg/inh, 200 mcg-25 mcg/inh |
|
|
|
|
Last updated: Mar. 3, 2023
Due to national shortage of the nebulization solutions, the formulary status of inhaler products has been temporarily adjusted to formulary, restricted to use during the albuterol/Duoneb shortage. Upon shortage resolution, these products will automatically return to their original formulary status. See Albuterol/Duoneb Shortage Mitigation for more information. (Updated Feb 2023)
ORDER FORMULATION
THERAPEUTIC INTERCHANGE
NOTES
fluticasone-vilanterol (Breo Ellipta)
budesonide-formoterol (Symbicort)
Interchange for adult patients.
fluticasone-vilanterol (Breo Ellipta)
budesonide-formoterol (Symbicort)
Interchange for pediatric patients.
Breo Ellipta medication guide
Reviewed: January 28, 2014